Blood biomarker testing for mesenteric ischemia
Official title: Mesenteric Ischemia Markers Study In The Presence Of Mesenteric Arteries Disease
Run by Belarusian State Medical University · NCT07460700 · Data updated 2026-11-12
This study will test whether specific blood biomarkers can reliably detect mesenteric ischemia and distinguish non‑transmural from transmural disease in adults with suspected mesenteric artery problems.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Belarusian State Medical University Academic / other |
| Locations | 1 site (Minsk) |
| Status | Recruiting |
| Started | December 22, 2025 |
| Main results expected | September 12, 2026 |
| Study ends | December 12, 2026 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT07460700 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with angiographic visualization and clinical suspicion of mesenteric arterial disease who can give informed consent and do not have pregnancy or disqualifying prior major abdominal/mesenteric surgery are ideal candidates.
✕Probably not a fit
Patients who do not have mesenteric ischemia, who are pregnant, who have had major prior operations on the mesenteric arteries or digestive organs, or who cannot consent or attend the study site are unlikely to receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective interventional study will collect blood samples from adults who have undergone angiographic visualization and are suspected of having mesenteric arterial disease. Investigators will measure multiple candidate biomarkers and analyze combinations to identify signatures that separate non‑transmural from transmural ischemia. The protocol emphasizes methodological rigor to address prior low‑quality and heterogeneous evidence. The goal is to produce validated biomarker panels that could be used for earlier risk stratification in clinical practice.
Why it matters
Potential benefit: If successful, validated biomarkers could enable earlier diagnosis and treatment of mesenteric ischemia, potentially reducing morbidity and mortality.
How similar studies have gone: Previous studies of blood biomarkers for mesenteric ischemia have been limited and produced inconsistent, low‑quality results, so reliable validation is still lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older, all sex * Initial decision, the presence of angio-visualisation of the MA and suspicion of mesenteric arteries diseases * Patient's consent to participate in the study * No pregnancy, no history of major operations on MA, the gastrointestinal tract and digestive organs (except appendectomy, endoscopic polypectomy). Exclusion Criteria: * Consent declined by patient or relatives * Failure to meet inclusion criteria
Where it's running
-
Belarusian State Medical University
Minsk, Belarus Recruiting
Study contacts
- Study coordinator: Hleb But-Husaim, PhD
- Email: dr.buthusaim@gmail.com
- Phone: +375256139407
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing colon anastomotic leaks by stenting the superior mesenteric artery
This trial tests whether placing a stent in the superior mesenteric artery before elective colon surgery can reduce anastomotic leaks in patients over 40 with an asymptomatic >50% SMA stenosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.